Public Profile

Precigen, Inc.

Precigen, Inc., a pioneering biotechnology company headquartered in the United States, focuses on advancing gene and cell therapies to address significant unmet medical needs. Founded in 2013, Precigen has rapidly established itself in the biopharmaceutical industry, particularly in the fields of immuno-oncology and genetic medicine. The company is renowned for its innovative platforms, including UltraCAR-T™ and AdenoVerse™, which enable the development of unique therapies designed to enhance patient outcomes. With a commitment to transforming healthcare, Precigen has achieved notable milestones, including strategic partnerships and advancements in clinical trials. Positioned as a leader in the biotechnology sector, Precigen continues to push the boundaries of science, striving to deliver cutting-edge solutions that redefine treatment paradigms and improve the lives of patients worldwide.

DitchCarbon Score

How does Precigen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Precigen, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Precigen, Inc.'s reported carbon emissions

Precigen, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or evaluate their climate commitments. However, the company is likely aware of the growing importance of sustainability and may be exploring initiatives to address climate change in line with industry standards. As the landscape of corporate responsibility evolves, Precigen may consider setting measurable targets in the future to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Precigen, Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Precigen, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Precigen, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Aptim

US
Other services (93)
Updated 1 day ago

Iovance Biotherapeutics

US
Education services (80)
Updated 5 days ago

Applied DNA Sciences

US
Leather and leather products (19)
Updated 5 days ago

Poseida Therapeutics, Inc.

US
Health and social work services (85)
Updated 29 days ago
DitchCarbon Score

Juno Therapeutics, Inc.

US
Health and social work services (85)
Updated 5 days ago

Incyte

US
Health and social work services (85)
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers